Atopic dermatitis (AD) is a chronic inflammatory skin disease in humans. It was recently noted that the characteristics of epidermal barrier functions critically influence the pathological features of AD. Evidence suggests that claudin-1 (CLDN1), a major component of tight junctions (TJs) in the epidermis, plays a key role in human AD, but the mechanism underlying this role is poorly understood. One of the main challenges in studying CLDN1's effects is that Cldn1 knock-out mice cannot survive beyond 1 d after birth, due to lethal dehydration. Here, we established a series of mouse lines that express Cldn1 at various levels and used these mice to study Cldn1's effects in vivo. Notably, we discovered a dose-dependent effect of Cldn1's expression in orchestrating features of AD. In our experimental model, epithelial barrier functions and morphological changes in the skin varied exponentially with the decrease in Cldn1 expression level. At low Cldn1 expression levels, mice exhibited morphological features of AD and an innate immune response that included neutrophil and macrophage recruitment to the skin. These phenotypes were especially apparent in the infant stages and lessened as the mice became adults, depending on the expression level of Cldn1. Still, these adult mice with improved phenotypes showed an enhanced hapten-induced contact hypersensitivity response compared with WT mice. Furthermore, we revealed a relationship between macrophage recruitment and CLDN1 levels in human AD patients. Our findings collectively suggest that CLDN1 regulates the pathogenesis, severity, and natural course of human AD.
C laudins, a multigene family with at least 27 members in human and mouse, are the main components of tight junctions (TJs) (1) , which create the paracellular barrier and, in some cases, the channel functions of epithelial cell sheets (2, 3) . The expression patterns of claudins vary according to cell type and contribute to a variety of paracellular barrier functions that specifically maintain the homeostasis of tissues and organs (4) . In the skin, TJs are key contributors to the epidermal paracellular barrier, and claudin-1 (CLDN1), a main component of TJs in the epidermis, is reported to be indispensable for this barrier function; abnormalities in CLDN1 cause human skin diseases (5) (6) (7) (8) (9) . However, because Cldn1 knock-out (KO) mice die within 1 d of birth due to dehydration (10, 11) , it has been difficult to study how Cldn1 contributes to skin diseases.
Recent evidence indicates that atopic dermatitis (AD), which is a common chronic inflammatory skin disease (12, 13) , is associated with decreased CLDN1 expression levels in humans (8, 14) . AD appears in ∼20% of children and 3% of adults, and its symptoms include itching and eczema, which decrease patients' quality of life (15) . Around 70% of AD cases start in children under 5 y of age, and the disease tends to show spontaneous remission with aging (16, 17) . Although immunological imbalances were previously proposed to explain the features of AD, such as increased immunoglobulin E (IgE) levels and the acquired immune response, recent studies showed that epidermal barrier functions critically influence the pathological features of AD (18, 19) . However, the cause and development of AD with respect to epidermal barrier functions have not been systematically studied.
Here, we established a experimental model system consisting of mouse lines in which the Cldn1 expression was systematically regulated to elicit different levels of expression. Although many gene functions have been uncovered using a gene KO strategy in mice to compare the all-vs.-none situations, an alternative approach examines how variations in gene expression levels can change the normal function of a gene, sometimes leading to disease. Using our systematic Cldn1 knock-down (KD) mouse system, we revealed the in vitro and in vivo responses to dosedependent expression levels of Cldn1, and the relationship between Cldn1 expression and AD. The epithelial barrier functions and morphological changes in the skin varied exponentially with the decreased expression level of Cldn1. The Cldn1 KD mice mimicked human AD in several respects: They showed morphological features typical of AD and similar innate immune responses, both of which improved with age. However, the Cldn1 KD skin that had improved with age was still weakened against the penetration of hapten compared with WT. Our findings suggest that the severity of these features is determined by the expression level of CLDN1 in human AD. In support of this possibility, we found that macrophage recruitment to the skin was related to the protein expression level of CLDN1 in human AD patients. Taking these findings together, we propose that a decreased expression of CLDN1 may be a critical risk factor for the pathogenesis and progression of AD.
Significance
Claudin-1 (CLDN1), which is thought to be a key gene for human skin disease, especially atopic dermatitis (AD), encodes the dominant claudin responsible for the paracellular barrier at tight junctions in the epidermis. Although decreased CLDN1 expression levels are reported in AD patients, it has been difficult to study how CLDN1 contributes to AD development, mainly because Cldn1 knock-out mice die within 1 d after birth from dehydration. In this report, we reproduced features of human AD in mice, by systematically regulating the Cldn1 expression level. Our experimental approach contributes to the understanding of AD's etiology and suggests a therapeutic target for this disorder. (Fig. 1A) . First, we generated Cldn1 mutant (conditional) KO mice ( Fig. S1 ), using a strategy in which insertion of the neo gene down-regulates floxed gene expression levels (20, 21) . We observed that the neo-flox allele led to significant reductions in the Cldn1 gene expression and protein levels ( Fig. S2 A and B) . By exploiting this phenomenon, we obtained mice with six different Cldn1 expression levels: Cldn1
, and Cldn1
. This series of mutant mouse lines served as a sophisticated experimental model with which to examine the role of Cldn1.
To determine the expression levels of Cldn1 quantitatively, we prepared primary keratinocyte cultures from newborn mice of each genotype. Real-time (RT) PCR confirmed that the Cldn1 mRNA levels differed according to genotype (Fig. 1B) . In addition, immunoblots of Cldn1 and β-actin showed a similar pattern of Cldn1 protein levels for each genotype (Fig. S2 C and D) . The results revealed a strong positive correlation between the Cldn1 mRNA and protein levels ( Fig. 1C and Fig. S2 A, B , and D).
Exponential Correlations of the Expression Level of Cldn1 with Its
Epithelial Barrier Function and with the Phenotype in Vivo. To examine the relationship between Cldn1 expression levels and the phenotypes of our mouse lines, we first analyzed the paracellular barrier function of the skin epithelium. For this analysis, we measured the transepithelial electrical resistance (TER) and paracellular flux (FLUX) of 4-kDa dextran tracers in primary cultures of keratinocytes prepared from each mouse line. Although the Cldn1 mRNA level was proportional to its protein level (Fig. 1C) , the TER and FLUX results showed that the barrier function in keratinocyte changed exponentially as the Cldn1 mRNA expression level increased ( Fig. 1D and Fig. S3A ). The t 1/2 values for the plateaus of the TER and FLUX data corresponded approximately to the mRNA level in Cldn1 Δ/-keratinocytes, which was 10% of the level in WT (Fig. S3B) . Furthermore, we observed a difference in permeability in vivo by tracer experiments using a biotinylation reagent (Fig. S3C ). In the Cldn1 Δ/-and Cldn1 −/− newborn epidermis, the biotinylation reagent leaked through occludin-positive TJs. Notably, immunohistochemical analyses revealed that the Cldn1 −/− keratinocytes still contained TJs (Fig. S4A ). In addition, the Claudin-3 and Occludin mRNA levels tended to be correlated with the level of Cldn1 mRNA expression whereas other junctional components, including Claudin-4, Tricellin, ZO-1, ZO-2, E-cadherin, and K5, did not (Fig.  S4B ). These findings indicated that the differences in the paracellular barrier functions of keratinocytes were closely related to the Cldn-1 expression levels in vivo.
We next examined the Cldn1-dependent morphological changes in the epidermis of newborn mice. Previous reports showed that Cldn1 affects the stratum granulosum (SG), from which the stratum corneum (SC) is generated, and that Cldn1 −/− newborn mice have an abnormal SC (10, 11) . In our experimental model, H&E staining revealed that not only Cdln1 −/− but also Cldn1 Δ/Δ and 
Cldn1
Δ/-newborn mice showed abnormal differentiation of the SC, the severity of which was correlated with the epithelial barrier function and Cldn1 expression level (Fig. 1E ). These findings indicated that differences in the paracellular barrier functions and morphology of the epidermis were closely related to the Cldn-1 expression level in vivo.
Cldn1 Expression Level-Dependent Regulation of AD Phenotypes in
Mice at Different Ages. To understand CLDN1's role in the agerelated changes in human AD, we examined the phenotypes of the model mice over time, from birth to adulthood. Although the Cldn1 −/− mice died within 1 d of birth, the other genotypes survived to adulthood with varying mortality rates. The survival rate at 8 wk was over 80% for Cldn1
, and Cldn1 Δ/Δ ; 4% for Cldn1 Δ/-; and 0% for Cldn1 −/− mice (Fig. S5A) . These results suggested that the low Cldn1 expression level in Cldn1 Δ/-mice was near the threshold for lethality.
Among the Cldn1 mutant mice, the Cldn1 Δ/Δ and Cldn1 Δ/-mice showed age-dependent changes in their skin appearance ( Fig. 1F and Fig. S5 B-E). Cldn1 Δ/Δ mice showed wrinkled skin at 1 wk, showed abnormal dry hair at 2 wk, and were nearly normal at 8 wk. The Cldn1 Δ/-mice, which usually did not survive beyond weaning, showed more severe skin phenotypes with severe desquamation and wrinkled skin at 2 wk; this phenotype had improved but was still apparent at 8 wk, and only the Cldn1 Δ/-mice, of all of the mutant genotypes, still exhibited a different severity of skin lesion from WT at 8 wk by dermatitis score (Fig. S6D) (22) . Overall, these findings revealed that the decreased expression of Cldn1 caused severe skin defects in infancy that improved with age in the mouse, similar to the natural history of infantile eczema in human AD patients (16). Cldn1 Expression Level-Dependent Morphological Features of the Epidermis. We next performed a detailed analysis of the skin morphology of the Cldn1 mutant mice with aging. H&E-stained preparations from 2-and 8-wk-old mice revealed pathological characteristics of the Cldn1 Δ/Δ and Cldn1 Δ/-skin, including hyperkeratosis, acanthosis, and increased numbers of hair follicles ( Fig. 2 A and B) . Immunofluorescence staining showed that Cldn1 localized only at the SG layer in Cldn1 KD epidermis, and the TJs in 2-wk-old Cldn1 Δ/-epidermis lacked CLDN1 (Fig. 2C) . The expression domain of keratin-5 (K5), a basal epidermis marker, was restricted to the most basal layers in the Cldn1 +/+ epidermis but expanded to the suprabasal layers in the Cldn1 Δ/Δ and Cldn1 Δ/-epidermis (Fig. 2D ). In addition, the 2-wk-old Cldn1 Δ/-mice showed ectopic proliferation in the subapical basal layer, as indicated by Ki-67 staining (Fig. S6A) . In contrast, the mutant mice showed the same expression domain for keratin-10 (K10), a marker for the stratum spinosum and SG layers, as the Cldn1 +/+ mice (Fig. S6B) . Similar changes in the expression domains of the human orthologs of these molecules were found in AD patients (see Fig. 4A ) (Fig. S7 A-D and Dataset S1), consistent with a previous report (23) . These findings suggested that a decrease in Cldn1 expression causes abnormal skin differentiation in the infant stages, especially in the proliferation layers, and that the skin of Cldn1 KD mice mimics the changes seen in human AD tissue.
Correlation of Cldn1 Expression Level with Immunological Features of the Epidermis. In human AD patients, both macrophages and neutrophils are recruited to the skin to eliminate pathogens (24, 25) . In our experimental model, substantial numbers of Gr-1-positive neutrophils were detected in Cldn1 Δ/Δ and Cldn1 Δ/-mouse skin samples at 2 wk, and very few were seen at 8 wk (Fig.  3A and Fig. S6C ). F4/80-positive macrophages were detected in the Cldn1 Δ/Δ mouse epidermis at 2 wk but not at 8 wk, and in the Cldn1 Δ/-skin at both 2 and 8 wk (Fig. 3B and Fig. S6D ). Realtime RT-PCR showed similar levels of inflammation markers between Cldn1 +/+ and the Cldn1 KD mouse series in newborns (Fig. 3C) . By 1 wk, however, the skin of Cldn1 Δ/-infants showed higher expression of the proinflammatory marker IL-β, which later decreased in the adults, consistent with the visible neutrophil infiltration. A similar pattern was observed for the expression of the neutrophil chemoattractant KC in the Cldn1 Δ/Δ and Cldn1 Δ/-skin, and of the macrophage chemoattractant MCP-1 in the Cldn1 Δ/-skin. These phenotypes were apparent in the infant stages and lessened as the mice became adults, depending on the expression levels of Cldn1, similar to the morphological changes in the epidermis. We next tested the hapten-induced contact hypersensitivity (CHS) in Cldn1 Δ/Δ adult mice, in which the morphological and immunological features had improved with age. For this test, we used the contact allergen 2,4-dinitrofluorobenzene (DNFB) and evaluated the cellular immune responses as described previously (26) . We found that the Cldn1 Δ/Δ ear skin thickness was significantly increased, and the H&E-stained preparations showed more severe edema and inflammation, compared with Cldn1 +/+ (Fig. 3D) . Most AD skin lesions in humans are characterized by an immune response in which Th2-related cytokines and elevated IgE levels are accompanied by an increased number of Th1-related cytokine-producing cells (27) . In our mice at 2 wk of age, the Cldn1 Δ/-skin showed significantly higher levels of IL-12p35, IL-12p40, IFN-γ, and IL-10 by real-time RT-PCR, compared with the Cldn1 +/+ skin (Fig. 3E) . In contrast, IL-4 was not significantly different between the Cldn1 +/+ and Cldn1 KD skin. In Cldn1 Δ/-lymph nodes, IL-12p40, but not IL-4, was significantly higher than in Cldn1 +/+ lymph nodes (Fig. S6E) . Consistent with these findings, the serum of Cldn1 Δ/Δ and Cldn1 Δ/-mice contained less than 0.1 μg/mg IgE (Fig. S6F) . That the Cldn1 KD mice showed these immunological features despite living in specific pathogenfree (SPF) conditions suggested that skin-homing innate immune cells, which were also found in human AD patients, may be recruited to provide a second line of defense against invading pathogens, and that this recruitment may be associated with the fragility of the epidermal barrier in AD in the absence of pathogen detection (Fig. S7 E and F and Dataset S1).
Relationship Between CLDN1 Levels and AD Features in Humans. We next examined the CLDN1 expression in human AD patients, to determine whether the expression levels could play a similar role in AD as in our mouse model. For this purpose, we immunofluorescently labeled the CLDN1 in skin samples from 12 AD patients and 4 control subjects and compared the CLDN1 levels semiquantitatively. The levels of CLDN1 were significantly lower in the skin of AD patients compared with controls ( Fig. 4 A and  B and Fig. S8 ). In skin samples from the trunk and limbs of human AD patients, after removing the outlier CLDN1 signals, we found that the number of macrophages was significantly inversely correlated with the CLDN1 signal (Fig. 4C) . On the other hand, we found no correlation between the CLDN1 level and the thickness of the epidermis, the severity of AD by Eczema Area and Severity Index (EASI), or the serum level of defined AD factors, including leukocytes, eosinophils, IgE, or thymus and activation-regulated chemokine (TARC) (Fig. S9 and Dataset S1). Thus, macrophage recruitment was dramatically increased in the context of decreased CLDN1 levels, but AD factors were not increased. Considering that human AD is caused by complex factors culminating in the atopic disposition, it is remarkable that the macrophage recruitment was directly affected by CLDN1. These findings suggest that the CLDN1 expression level regulates disease symptoms in human AD.
Discussion
In this study, we established mouse lines in which the Cldn1 expression levels were systematically regulated and used them to elucidate the relationship between Cldn1 and AD. This experimental approach presents a sophisticated model with which to explore how different levels of gene expression determine the severity of diseases. Although previous studies reported that the CLDN1 expression is decreased in human AD, the effect of different expression levels was not critically examined. Here, we revealed the effects of different Cldn1 expression levels on the AD phenotypes of mice in vivo.
We found that Cldn1 has roles in both epithelial barrier and morphological changes. TER and FLUX measurements in cultured keratinocytes prepared from each mutant mouse showed that the Cldn1 expression levels were exponentially correlated with epithelial barrier function. The t 1/2 values for the plateaus of the TER and FLUX data, deduced from the values in Cldn1 +/+ keratinocytes, were closely correlated with the CLDN1 protein level in Cldn1 Δ/-keratinocytes. Consistent with these findings, an in vivo permeability assay using a biotinylation reagent showed that Cldn1 Δ/-and Cldn1 −/− newborn skin exhibited significantly increased paracellular permeability through the occludin-positive TJs. Half of the Cldn1 Δ/-mice died within 1 d, and only 4% of them survived to 8 wk. These findings suggested that this t 1/2 Cldn1 concentration for epithelial barrier function dramatically affects homeostasis in vivo. Furthermore, H&E staining showed that differentiation abnormalities of the SC were correlated with the epithelial barrier function. These results in mice suggested that AD phenotypes appeared at Cldn1 mRNA expression levels that were less than 20% of the Cldn1 +/+ mRNA level. Together, these findings in mice support the notion that a decrease in CLDN1 expression levels is a critical risk factor for human AD.
We also used our series of mutant mouse lines to demonstrate the effect of decreased Cldn1 expression in adult Cldn1 mutant mice, which would be impossible to study using Cldn1 KO mice, which die within 1 d of birth. With aging, the reduced Cldn1 expression levels caused hyperkeratosis and acanthosis, with inflammation that included neutrophil and macrophage recruitment to the skin. The phenotypes of the Cldn1 KD mice mimicked human AD with respect to its morphological features, innate immune response, and spontaneous improvement with age, revealing a similarity to the natural history of infantile eczema in human AD (16) . However, even after improvement, the Cldn1 Δ/Δ epidermis did not function comparably to the Cldn1
epidermis. In this respect, the Cldn1 KD adult mice showed enhanced hapten-induced CHS responses, indicating that the recovery of the skin condition in Cldn1 KD is insufficient to defend the skin against percutaneous stimuli. Thus, our Cldn1 mutant mice provide a model system for studying the pathology of human AD at each age stage. Two main hypotheses to explain AD have been previously proposed. The first is that an immunological imbalance of the adaptive immune response causes inflammatory lesions. In this respect, the adaptive immune response is associated with increased levels of Th2 cytokines and IgE, which play central roles in the pathogenesis of AD. Moreover, recent papers suggest that inflammation causes Cldn1 to be down-regulated (9, 28) . The second hypothesis is that skin barrier defects increase the risk of developing AD. A recent study showed that mutation of the gene for filaggrin, an epidermal barrier-related protein, induces AD in humans (29) . However, unlike in human AD, filaggrin-deficient mice do not show an adaptive immune response in the absence of penetrating antigen (26) . Likewise, the Cldn1 KD mice in the present study did not show an adaptive immune response. In this respect, the paracellular barrier dysfunction caused by claudin-18 deficiency in TJs triggers inflammation in the mouse stomach (30) , and mice with SC barrier dysfunction exhibit skin inflammation (31, 32) . Considering that Cldn1 reduction affects the paracellular barrier (as shown here) and SC barrier function (11, 33) , it is likely that a reduced Cldn1 expression level severely down-regulates the epidermal barrier in vivo and that the resulting changes in the skin lead to inflammation with an innate immune response. Our findings support at least the second hypothesis to explain AD and imply that the immunological features of AD may be acquired with age due to environmental effects, as a result of the disrupted barrier (34, 35) . In any case, evidence suggests that CLDN1 plays an important role in either hypothesis.
On the other hand, we found that, in human AD patients, the number of macrophages was inversely correlated with the CLDN1 level although we could not find a correlation between CLDN1 staining intensity and the severity of AD or Th2 markers in the AD patients' serum. Immunofluorescence micrographs showed that macrophages were present in the adult skin of Cldn1 Δ/Δ and Cldn1 Δ/-mice, implying that CLDN1 regulates macrophage recruitment at later stages. To further explore the correlation between barrier function and AD, experiments performed under a variety of conditions, on a large scale, and over the long term in mice and humans are required.
Our study of the in vivo response to decreased Cldn1 expression levels in mouse revealed that Cldn1 plays a critical role in AD, several features of which were related to the Cldn1 expression level. These results provide strong evidence that CLDN1-induced changes in barrier functions have potential roles in the pathogenesis, severity, and natural course of AD and suggest that the immunological features of AD depend on the external environment (Fig. 4D) . Our finding that Cldn1 orchestrates the features of AD in a time-and dose-dependent manner in vivo provides insight into the etiology of AD and suggests a potential target for future therapies.
Materials and Methods
Generation of Cldn1 Mutant Mice. Chimeric mice were generated as described (www2.clst.riken.jp/arg/Methods.html) and crossed with C57BL/6J mice to obtain heterozygous Cldn1 flox/wt mice (accession no. CDB0818K; www2.clst.
riken.jp/arg/mutant%20mice%20list.html). The WT allele was distinguished by PCR using Cldn1-s1 (ggaactatcagacaagaggtgccc) as the sense, and Cldn1-as1 (cgctgtgatttaaagcagctccgc) as the antisense primer, which amplified a 408-bp fragment. The targeted allele was distinguished using Cldn1-s2 (catgagtgggaggaatgagctgg) as the sense, and Cldn1-as1 as the antisense primer, which amplified a 300-bp fragment. The deleted allele was distinguished by PCR using Cldn1-s1 as the sense, and Cldn1-as2 (cgcttgtaaacctacccaaagtgtgcc) as the antisense primer, which amplified a 645-bp fragment. All the primers used in this study are shown in Fig. S1 .
Mouse Treatment. Mice were backcrossed for five generations to C57BL/6J (Japan SLC, Inc.) and kept under SPF conditions. All animal studies in this report were approved by the Institutional Animal Care Committee of RIKEN Kobe Branch and Osaka University. The pictures of mice were captured with an EOS 50D camera (Canon) with identical settings and converted to gray scale to adjust the white balance.
Preparation of Mouse Keratinocytes. Keratinocytes were isolated from the trunk skin of newborn mice by Dispase and cultured in the epidermal keratinocyte culture medium from CELLnTEc. Differentiation was initiated by increasing the Ca 2+ concentration from 0.07 mM to 2.0 mM. For immunofluorescence and immunoblots, the cells were fixed or collected after a 24-h incubation at the high Ca 2+ concentration. Barrier assays were started after the cells were incubated at the high Ca 2+ concentration for 48 h.
Quantitative Real-Time RT-PCR. Real-time PCR with SYBR Green was used to measure the mRNA levels. The RNAs were reverse transcribed to cDNA by SuperScript II reverse transcriptase. Sequences of the specific primers are listed in Table S1 . The designed specific primers were described previously (30, (36) (37) (38) (39) (40) (41) . Gene expression was normalized to the GAPDH expression by calculating the Δ Ct = (Ct of GAPDH − Ct of the gene). Setting the expression value of GAPDH to 1.0, the relative expression values were calculated as 2 ΔCt .
Barrier Function Assay. In cultured primary keratinocytes, TER and Flux measurements were performed after keratinocyte differentiation on a Transwell filter. The TER was measured directly in culture medium using an epithelial volt-ohm meter (model Millicell-ERS; Millipore). For the paracellular tracer flux assay, 1 mg/mL 4-kDa FITC-dextran was added to the medium in the apical compartment. After a 24-h incubation, the medium was collected from the basal compartment, and the amount of FITC-dextran was determined by fluorometer. The values were normalized to that obtained for Cldn1 +/+ mice. In newborn skin, the biotinylation tracer experiment was performed as previously described (10) .
Evaluation of Hapten-Induced Contact Hypersensitivity. The hapten-induced CHS was evaluated as previously described (26) . We examined the tissue immune response 0, 4, 8, 12, and 24 h after DNFB challenge. For the histological analyses, samples were collected 48 h after DNFB challenge.
Human Samples. All human samples, which were embedded in paraffin in a tissue bank, were obtained by Osaka University Hospital under an agreement that they would be used for research. The use of human skin samples for this study was approved by the ethical committee of Osaka University Graduate School of Medicine (Institutional ID of approval; 13429). We obtained 12 AD samples and 4 control samples, the detailed properties of which are noted in Dataset S1. For staining, the paraffin-embedded skin tissues were sectioned, deparaffinized with xylene, and dehydrated by a graded ethanol series. The deparaffinized sections were boiled in an oil bath for 16 min in 10 mM Tris-1 mM EDTA (pH 9.0) for antigen retrieval. The slides were rinsed with PBS and blocked with Protein Block Serum-Free solution (Dako) for 15 min. The slides were incubated with primary antibodies at room temperature for 1 h, rinsed with TBS containing 0.05% Tween, and treated with Dako LSAP + System-AP (DakoCytomation) for 25 min and Dako ChemMate Envision kit/ HRP (DAB), or with second antibodies for 30 min. Slides treated with DAB were counterstained with hematoxylin and mounted with Clear Plus (Falma). Sections treated with secondary antibodies were rinsed with PBS, counterstained with 4′6′-diamidino-2-phenylindole (DAPI), and mounted in Prolong Gold (Invitrogen). Images were captured with a light microscope or with a Zeiss LSM710 laser-scanning confocal microscope (Carl Zeiss MicroImaging). Macrophages were counted by three different individuals under light microscopy (Olympus BX43; Olympus) with a UPlan N 40× N.A. 0.75 lens. For each sample, three fields were counted and averaged. For the semiquantitative analysis, micrographs were normalized by subtracting the background intensity of the basal layers in the epidermis using ImageJ software (NIH). The outlier scores were determined by boxplot analysis using the free software R.
